Lesion-Specific Congenital Heart Disease Mortality Trends in Children: 1999 to 2017

Melodie M Lynn1,2, Jason L Salemi3,4, Stefan P Kostelyna2

  • 1Division of Pediatric Cardiology.

Pediatrics
|September 1, 2022
PubMed

Insights

Pediatric congenital heart disease (CHD) mortality is declining overall, but single ventricle lesions remain a major cause of death in children. Risk factors like prematurity worsen outcomes for infant CHD deaths.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Medical Statistics

Background:

  • Congenital heart disease (CHD) is a primary cause of infant and child mortality.
  • Data on lesion-specific mortality trends in pediatric CHD are limited.
  • Understanding these trends is crucial for improving outcomes.

Purpose of the Study:

  • To analyze pediatric mortality trends stratified by specific congenital heart disease lesions in the United States.
  • To identify temporal changes in CHD mortality from 1999 to 2017.
  • To examine the impact of contributing risk factors on CHD mortality.

Main Methods:

  • Utilized 19-year (1999-2017) mortality data from the National Center for Health Statistics.
  • Stratified analysis by CHD diagnosis and age groups (infants, 1-4 years, 5-17 years).
  • Employed joinpoint regression to analyze temporal trends and risk factor effects.

Main Results:

  • Infant mortality was highest across all CHD lesions, particularly for total anomalous pulmonary venous return.
  • Most lesions showed significant declines in infant CHD mortality.
  • Single ventricle lesions exhibited the highest mortality rates across all ages, with increasing rates in older children (5-17 years).
  • Contributing factors like prematurity and genetic conditions were present in 19% of infant deaths and associated with worse trends.

Conclusions:

  • Congenital heart disease mortality is decreasing for most lesions.
  • Mortality trends vary significantly by lesion type and age group.
  • Single ventricle lesions represent a persistent challenge, contributing significantly to premature death, especially in children aged 5-17 years.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29